Stericycle Inc. (NASDAQ:SRCL) – Equities researchers at Wedbush increased their Q3 2016 earnings estimates for Stericycle in a note issued to investors on Thursday. Wedbush analyst A. Kaschalk now anticipates that the firm will post earnings per share of $1.20 for the quarter, up from their prior estimate of $1.19. Wedbush has a “Neutral” rating and a $85.00 price objective on the stock. Wedbush also issued estimates for Stericycle’s Q1 2017 earnings at $1.11 EPS, Q2 2017 earnings at $1.15 EPS, FY2017 earnings at $4.75 EPS, Q1 2018 earnings at $1.19 EPS and FY2018 earnings at $5.12 EPS.
Stericycle (NASDAQ:SRCL) last issued its earnings results on Thursday, July 28th. The company reported $1.18 EPS for the quarter, meeting analysts’ consensus estimates of $1.18. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The business earned $891.60 million during the quarter, compared to analyst estimates of $910.29 million. During the same period in the previous year, the company posted $1.14 EPS. The firm’s revenue was up 24.6% compared to the same quarter last year.
Several other analysts have also issued reports on the stock. RBC Capital Markets restated an “underperform” rating and set a $77.00 price target (down from $89.00) on shares of Stericycle in a research report on Monday, September 19th. Macquarie initiated coverage on shares of Stericycle in a research report on Thursday, August 25th. They set a “neutral” rating and a $96.00 price target for the company. Wellington Shields lowered shares of Stericycle from an “accumulate” rating to a “hold” rating in a research report on Friday, July 29th. Jefferies Group restated a “buy” rating and set a $125.00 price target on shares of Stericycle in a research report on Tuesday, August 23rd. Finally, Imperial Capital lowered shares of Stericycle from an “in-line” rating to an “underperform” rating and cut their price target for the company from $100.00 to $93.50 in a research report on Friday, July 29th. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average price target of $104.95.
Shares of Stericycle (NASDAQ:SRCL) opened at 79.54 on Monday. The company has a market capitalization of $6.76 billion, a price-to-earnings ratio of 28.00 and a beta of 0.27. The company has a 50-day moving average price of $83.98 and a 200-day moving average price of $102.01. Stericycle has a 12 month low of $76.76 and a 12 month high of $151.57.
A number of institutional investors have recently added to or reduced their stakes in the company. Jana Partners LLC acquired a new position in shares of Stericycle during the first quarter worth $305,997,000. First Republic Investment Management Inc. increased its position in shares of Stericycle by 23.9% in the first quarter. First Republic Investment Management Inc. now owns 296,838 shares of the company’s stock worth $37,457,000 after buying an additional 57,220 shares in the last quarter. Douglas Lane & Associates LLC increased its position in shares of Stericycle by 6.6% in the second quarter. Douglas Lane & Associates LLC now owns 346,276 shares of the company’s stock worth $36,054,000 after buying an additional 21,370 shares in the last quarter. Oakbrook Investments LLC acquired a new position in shares of Stericycle during the second quarter worth $13,871,000. Finally, Geode Capital Management LLC increased its position in shares of Stericycle by 2.7% in the first quarter. Geode Capital Management LLC now owns 729,638 shares of the company’s stock worth $91,897,000 after buying an additional 19,379 shares in the last quarter. 92.80% of the stock is owned by institutional investors.
In related news, EVP John P. Schetz sold 1,398 shares of the stock in a transaction dated Wednesday, September 14th. The shares were sold at an average price of $81.85, for a total value of $114,426.30. Following the completion of the transaction, the executive vice president now directly owns 1,088 shares of the company’s stock, valued at $89,052.80. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Rodney F. Dammeyer sold 10,188 shares of the stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total transaction of $871,074.00. Following the completion of the transaction, the director now directly owns 10,188 shares of the company’s stock, valued at $871,074. The disclosure for this sale can be found here. 3.30% of the stock is currently owned by corporate insiders.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.